Evidence map›Paper›PMID 42062289›Full record

ArticleNature communications2026

Creating highly active fluoroacetate dehalogenases via gate-based synergetic chain design.

Cui-Zhen Wang, Huisi Huang, Zhihui Hu, Longwei Gao, Zhi-Qiao Lin, Ming Shi, Zhiyong Song, Min Li, Yueming Wang, Ke-Wei Chen and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Cui-Zhen Wang *Key Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Department of General Intensive Care Unit of the Second Affiliated Hospital (Zhejiang University), Zhejiang University School of Medicine, Hangzhou, P. R. China.
Huisi Huang *State Key Laboratory of Bioactive Molecules and Druggability Assessment, Pharmacy College, Jinan University, Guangzhou, P. R. China.ORCID http://orcid.org/0009-0003-4201-4558
Zhihui Hu *Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, P. R. China.
Longwei Gao *Key Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Department of General Intensive Care Unit of the Second Affiliated Hospital (Zhejiang University), Zhejiang University School of Medicine, Hangzhou, P. R. China.
Zhi-Qiao Lin *Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, P. R. China.
Ming ShiKey Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Department of General Intensive Care Unit of the Second Affiliated Hospital (Zhejiang University), Zhejiang University School of Medicine, Hangzhou, P. R. China.
Zhiyong SongKey Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, P. R. China.
Min LiKey Laboratory of Tea Science of Ministry of Education, College of Horticulture, Hunan Agricultural University, Changsha, P. R. China.ORCID http://orcid.org/0009-0006-8611-9732
Yueming WangKey Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Department of General Intensive Care Unit of the Second Affiliated Hospital (Zhejiang University), Zhejiang University School of Medicine, Hangzhou, P. R. China.
Ke-Wei ChenLab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, P. R. China.ORCID http://orcid.org/0009-0002-3579-240X
Yu LiuCollege of Life Sciences, Zhejiang University, Hangzhou, P. R. China.
Yuanhong MaKey Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, P. R. China.ORCID http://orcid.org/0000-0001-6300-6897
Bo ChenKey Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education) and Key Laboratory of Phytochemistry R&D of Hunan Province, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, P. R. China.
Qipeng YanHunan Provincial Key Laboratory of Animal Models and Molecular Medicine, School of Biomedical Sciences, Hunan University, Changsha, Hunan, P. R. China. yqp-chembio@qq.com.ORCID http://orcid.org/0009-0002-8582-0210
Zhi-Min ZhangState Key Laboratory of Bioactive Molecules and Druggability Assessment, Pharmacy College, Jinan University, Guangzhou, P. R. China. zhangzm@jnu.edu.cn.ORCID http://orcid.org/0000-0002-5088-5869
Jian-Bo WangKey Laboratory of Multiple Organ Failure (Zhejiang University), Ministry of Education, Department of General Intensive Care Unit of the Second Affiliated Hospital (Zhejiang University), Zhejiang University School of Medicine, Hangzhou, P. R. China. jwang2023@zju.edu.cn.ORCID http://orcid.org/0000-0003-1154-8437

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22034002National Natural Science Foundation of China (National Science Foundation of China) 22477110
6 · The paper itself

Abstract

Gate residues, acting in concert with distal dynamic networks, are emerging as critical yet underexploited regulators of enzymatic catalysis. Here we show that conformational dynamics analysis of fluoroacetate dehalogenase RPA1163 reveals a gate-based allosteric pair (K181-W185) that governs substrate access and reactivity. Network engineering of this pair yields a double mutant with high turnover number for α-fluorophenylpropionic acid (turnover number > 2 × 10⁵), establishing gate-centric allostery as a generalizable design principle. Structural and molecular dynamics analyses show that the activity enhancement arises from stabilization of catalytically competent open states through long-range coupling. Extension of this strategy to three additional dehalogenases confirms the universality of gate-based dynamic rewiring. Leveraging this framework, we establish a robust biocatalytic platform for stereoselective synthesis of α-fluoro and α-hydroxy carboxylic acids, achieving high productivity (turnover number > 3.7 × 10⁶) and enabling decagram-scale preparation of pharmaceutically relevant intermediates with high yield and enantioselectivity. Together, these findings establish gate-residue allostery as a powerful concept in protein engineering, bridging conformational dynamics with translational biocatalysis.

Indexed as

Bacterial ProteinsHydrolasesProtein EngineeringAllosteric RegulationBiocatalysisMolecular Dynamics SimulationProtein ConformationSubstrate SpecificityBacterial ProteinsHydrolases

Identifiers

PMID42062289
PMCPMC13328661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.